BIOLINE RXBIOLINE RXBIOLINE RX

BIOLINE RX

No trades
See on Supercharts

Price target

110.800.000.00%
The 3 analysts offering 1 year price forecasts for BLRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to BLRX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BLRX EPS for the last quarter is  ILA despite the estimation of −0.01 ILA. In the next quarter EPS is expected to reach −0.01 ILA. Track more of BIOLINE RX financials and stay on top of what is up with the company.
In the next quarter BIOLINE RX revenue is expected to reach ‪28.19 M‬ ILA. Check out BIOLINE RX revenue and earnings and make informed decisions.
According to analysts, BLRX price target is 110.80 ILA with a max estimate of 218.36 ILA and a min estimate of 48.52 ILA. Check if this forecast comes true in a year, meanwhile watch BIOLINE RX stock price chart and keep track of the current situation with BLRX news and stock market news.